nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.111	0.165	CbGbCtD
Metronidazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.103	0.152	CbGbCtD
Metronidazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.103	0.152	CbGbCtD
Metronidazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0786	0.117	CbGbCtD
Metronidazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0777	0.115	CbGbCtD
Metronidazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0531	0.0789	CbGbCtD
Metronidazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0507	0.0753	CbGbCtD
Metronidazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0452	0.0671	CbGbCtD
Metronidazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0265	0.0394	CbGbCtD
Metronidazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.025	0.0372	CbGbCtD
Metronidazole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00268	0.0637	CbGpPWpGaD
Metronidazole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00237	0.0563	CbGpPWpGaD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00194	0.046	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00165	0.0391	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00153	0.0363	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.0015	0.0356	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00134	0.0319	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00125	0.0296	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.029	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.0012	0.0284	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00109	0.0259	CbGpPWpGaD
Metronidazole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000985	0.0234	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000975	0.0231	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000888	0.0211	CbGpPWpGaD
Metronidazole—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000792	0.0188	CbGpPWpGaD
Metronidazole—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000762	0.0181	CbGpPWpGaD
Metronidazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000755	0.0179	CbGpPWpGaD
Metronidazole—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000645	0.0153	CbGpPWpGaD
Metronidazole—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00062	0.0147	CbGpPWpGaD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000585	0.0139	CbGpPWpGaD
Metronidazole—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000576	0.0137	CbGpPWpGaD
Metronidazole—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000554	0.0131	CbGpPWpGaD
Metronidazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000508	0.0121	CbGpPWpGaD
Metronidazole—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000469	0.0111	CbGpPWpGaD
Metronidazole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000463	0.011	CbGpPWpGaD
Metronidazole—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000451	0.0107	CbGpPWpGaD
Metronidazole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000443	0.0105	CbGpPWpGaD
Metronidazole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000425	0.0101	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.01	CbGpPWpGaD
Metronidazole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.00971	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00904	CbGpPWpGaD
Metronidazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000369	0.00877	CbGpPWpGaD
Metronidazole—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00128	CcSEcCtD
Metronidazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00127	CcSEcCtD
Metronidazole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00127	CcSEcCtD
Metronidazole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00126	CcSEcCtD
Metronidazole—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00126	CcSEcCtD
Metronidazole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00126	CcSEcCtD
Metronidazole—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00126	CcSEcCtD
Metronidazole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00126	CcSEcCtD
Metronidazole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00126	CcSEcCtD
Metronidazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00126	CcSEcCtD
Metronidazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00126	CcSEcCtD
Metronidazole—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00126	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00126	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00126	CcSEcCtD
Metronidazole—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00126	CcSEcCtD
Metronidazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000355	0.00842	CbGpPWpGaD
Metronidazole—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00124	CcSEcCtD
Metronidazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00124	CcSEcCtD
Metronidazole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00124	CcSEcCtD
Metronidazole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00124	CcSEcCtD
Metronidazole—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00123	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00123	CcSEcCtD
Metronidazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00123	CcSEcCtD
Metronidazole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00122	CcSEcCtD
Metronidazole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00121	CcSEcCtD
Metronidazole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00121	CcSEcCtD
Metronidazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00121	CcSEcCtD
Metronidazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00121	CcSEcCtD
Metronidazole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00121	CcSEcCtD
Metronidazole—Infection—Formoterol—chronic obstructive pulmonary disease	0.000343	0.0012	CcSEcCtD
Metronidazole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.0012	CcSEcCtD
Metronidazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00119	CcSEcCtD
Metronidazole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00119	CcSEcCtD
Metronidazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00119	CcSEcCtD
Metronidazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00119	CcSEcCtD
Metronidazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00119	CcSEcCtD
Metronidazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00119	CcSEcCtD
Metronidazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00119	CcSEcCtD
Metronidazole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00119	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000337	0.00799	CbGpPWpGaD
Metronidazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000336	0.00798	CbGpPWpGaD
Metronidazole—Infection—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00118	CcSEcCtD
Metronidazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00118	CcSEcCtD
Metronidazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00118	CcSEcCtD
Metronidazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00117	CcSEcCtD
Metronidazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00117	CcSEcCtD
Metronidazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00116	CcSEcCtD
Metronidazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00116	CcSEcCtD
Metronidazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00116	CcSEcCtD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000329	0.00781	CbGpPWpGaD
Metronidazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00115	CcSEcCtD
Metronidazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00114	CcSEcCtD
Metronidazole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00114	CcSEcCtD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.00771	CbGpPWpGaD
Metronidazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00114	CcSEcCtD
Metronidazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00113	CcSEcCtD
Metronidazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000321	0.00113	CcSEcCtD
Metronidazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00113	CcSEcCtD
Metronidazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00112	CcSEcCtD
Metronidazole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00112	CcSEcCtD
Metronidazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00111	CcSEcCtD
Metronidazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00111	CcSEcCtD
Metronidazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00111	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000314	0.0011	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.0011	CcSEcCtD
Metronidazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.0011	CcSEcCtD
Metronidazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000312	0.0011	CcSEcCtD
Metronidazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00109	CcSEcCtD
Metronidazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00109	CcSEcCtD
Metronidazole—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00031	0.00735	CbGpPWpGaD
Metronidazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000309	0.00733	CbGpPWpGaD
Metronidazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00108	CcSEcCtD
Metronidazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00108	CcSEcCtD
Metronidazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00108	CcSEcCtD
Metronidazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00107	CcSEcCtD
Metronidazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00107	CcSEcCtD
Metronidazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00107	CcSEcCtD
Metronidazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00107	CcSEcCtD
Metronidazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000303	0.00106	CcSEcCtD
Metronidazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00106	CcSEcCtD
Metronidazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00105	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00105	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00105	CcSEcCtD
Metronidazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00105	CcSEcCtD
Metronidazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00105	CcSEcCtD
Metronidazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00105	CcSEcCtD
Metronidazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00705	CbGpPWpGaD
Metronidazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00104	CcSEcCtD
Metronidazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Metronidazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Metronidazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Metronidazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Metronidazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Metronidazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00103	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00103	CcSEcCtD
Metronidazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00102	CcSEcCtD
Metronidazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00102	CcSEcCtD
Metronidazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00102	CcSEcCtD
Metronidazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00101	CcSEcCtD
Metronidazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00101	CcSEcCtD
Metronidazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00101	CcSEcCtD
Metronidazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.001	CcSEcCtD
Metronidazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.001	CcSEcCtD
Metronidazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.001	CcSEcCtD
Metronidazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000999	CcSEcCtD
Metronidazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000999	CcSEcCtD
Metronidazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.000998	CcSEcCtD
Metronidazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.000995	CcSEcCtD
Metronidazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.000994	CcSEcCtD
Metronidazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.000992	CcSEcCtD
Metronidazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.000992	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000988	CcSEcCtD
Metronidazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000987	CcSEcCtD
Metronidazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000979	CcSEcCtD
Metronidazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000979	CcSEcCtD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000278	0.0066	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00656	CbGpPWpGaD
Metronidazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.000971	CcSEcCtD
Metronidazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000971	CcSEcCtD
Metronidazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000963	CcSEcCtD
Metronidazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000963	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000274	0.0065	CbGpPWpGaD
Metronidazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000959	CcSEcCtD
Metronidazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000959	CcSEcCtD
Metronidazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000959	CcSEcCtD
Metronidazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000959	CcSEcCtD
Metronidazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.000955	CcSEcCtD
Metronidazole—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000948	CcSEcCtD
Metronidazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.000947	CcSEcCtD
Metronidazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.000946	CcSEcCtD
Metronidazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.000946	CcSEcCtD
Metronidazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000269	0.000944	CcSEcCtD
Metronidazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000944	CcSEcCtD
Metronidazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.000941	CcSEcCtD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00636	CbGpPWpGaD
Metronidazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000939	CcSEcCtD
Metronidazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000939	CcSEcCtD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00633	CbGpPWpGaD
Metronidazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.000936	CcSEcCtD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00627	CbGpPWpGaD
Metronidazole—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000927	CcSEcCtD
Metronidazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00091	CcSEcCtD
Metronidazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000905	CcSEcCtD
Metronidazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000905	CcSEcCtD
Metronidazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000254	0.000893	CcSEcCtD
Metronidazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.000893	CcSEcCtD
Metronidazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.000892	CcSEcCtD
Metronidazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.000891	CcSEcCtD
Metronidazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00089	CcSEcCtD
Metronidazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000249	0.000875	CcSEcCtD
Metronidazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00087	CcSEcCtD
Metronidazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00087	CcSEcCtD
Metronidazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000244	0.000858	CcSEcCtD
Metronidazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.000858	CcSEcCtD
Metronidazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000852	CcSEcCtD
Metronidazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000845	CcSEcCtD
Metronidazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.000844	CcSEcCtD
Metronidazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00084	CcSEcCtD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00567	CbGpPWpGaD
Metronidazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00083	CcSEcCtD
Metronidazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00083	CcSEcCtD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.0056	CbGpPWpGaD
Metronidazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000823	CcSEcCtD
Metronidazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000821	CcSEcCtD
Metronidazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000231	0.000813	CcSEcCtD
Metronidazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00081	CcSEcCtD
Metronidazole—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000805	CcSEcCtD
Metronidazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000228	0.000802	CcSEcCtD
Metronidazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.000802	CcSEcCtD
Metronidazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00534	CbGpPWpGaD
Metronidazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000224	0.000785	CcSEcCtD
Metronidazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000785	CcSEcCtD
Metronidazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000783	CcSEcCtD
Metronidazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.000771	CcSEcCtD
Metronidazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.000771	CcSEcCtD
Metronidazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00518	CbGpPWpGaD
Metronidazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000218	0.000765	CcSEcCtD
Metronidazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.000765	CcSEcCtD
Metronidazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000764	CcSEcCtD
Metronidazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000764	CcSEcCtD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00515	CbGpPWpGaD
Metronidazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00076	CcSEcCtD
Metronidazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00076	CcSEcCtD
Metronidazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000758	CcSEcCtD
Metronidazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.000757	CcSEcCtD
Metronidazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000215	0.000755	CcSEcCtD
Metronidazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000749	CcSEcCtD
Metronidazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000748	CcSEcCtD
Metronidazole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000746	CcSEcCtD
Metronidazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000744	CcSEcCtD
Metronidazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000735	CcSEcCtD
Metronidazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000733	CcSEcCtD
Metronidazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000728	CcSEcCtD
Metronidazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000726	CcSEcCtD
Metronidazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000723	CcSEcCtD
Metronidazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000722	CcSEcCtD
Metronidazole—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000722	CcSEcCtD
Metronidazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000721	CcSEcCtD
Metronidazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00072	CcSEcCtD
Metronidazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00072	CcSEcCtD
Metronidazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000717	CcSEcCtD
Metronidazole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000707	CcSEcCtD
Metronidazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000201	0.000705	CcSEcCtD
Metronidazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000697	CcSEcCtD
Metronidazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000695	CcSEcCtD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00462	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.0046	CbGpPWpGaD
Metronidazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00068	CcSEcCtD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00456	CbGpPWpGaD
Metronidazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000668	CcSEcCtD
Metronidazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00066	CcSEcCtD
Metronidazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000657	CcSEcCtD
Metronidazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000657	CcSEcCtD
Metronidazole—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000646	CcSEcCtD
Metronidazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000635	CcSEcCtD
Metronidazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000181	0.00429	CbGpPWpGaD
Metronidazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000628	CcSEcCtD
Metronidazole—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000623	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00419	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00414	CbGpPWpGaD
Metronidazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000609	CcSEcCtD
Metronidazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000607	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00017	0.00405	CbGpPWpGaD
Metronidazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000594	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000169	0.004	CbGpPWpGaD
Metronidazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00059	CcSEcCtD
Metronidazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000588	CcSEcCtD
Metronidazole—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000585	CcSEcCtD
Metronidazole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000562	CcSEcCtD
Metronidazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00377	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00374	CbGpPWpGaD
Metronidazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000551	CcSEcCtD
Metronidazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000541	CcSEcCtD
Metronidazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000534	CcSEcCtD
Metronidazole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000527	CcSEcCtD
Metronidazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000525	CcSEcCtD
Metronidazole—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000524	CcSEcCtD
Metronidazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000522	CcSEcCtD
Metronidazole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000514	CcSEcCtD
Metronidazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000507	CcSEcCtD
Metronidazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000505	CcSEcCtD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.0034	CbGpPWpGaD
Metronidazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000498	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00336	CbGpPWpGaD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000494	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00332	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000139	0.00329	CbGpPWpGaD
Metronidazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000484	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000137	0.00326	CbGpPWpGaD
Metronidazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000477	CcSEcCtD
Metronidazole—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000477	CcSEcCtD
Metronidazole—Infection—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000474	CcSEcCtD
Metronidazole—Shock—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000469	CcSEcCtD
Metronidazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000468	CcSEcCtD
Metronidazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000464	CcSEcCtD
Metronidazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000461	CcSEcCtD
Metronidazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000455	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00305	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00301	CbGpPWpGaD
Metronidazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000435	CcSEcCtD
Metronidazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000434	CcSEcCtD
Metronidazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000432	CcSEcCtD
Metronidazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000429	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00012	0.00284	CbGpPWpGaD
Metronidazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00042	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000118	0.0028	CbGpPWpGaD
Metronidazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000415	CcSEcCtD
Metronidazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000414	CcSEcCtD
Metronidazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000414	CcSEcCtD
Metronidazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000411	CcSEcCtD
Metronidazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000411	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00277	CbGpPWpGaD
Metronidazole—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000408	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00274	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0027	CbGpPWpGaD
Metronidazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000393	CcSEcCtD
Metronidazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00039	CcSEcCtD
Metronidazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00039	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00258	CbGpPWpGaD
Metronidazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000379	CcSEcCtD
Metronidazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000377	CcSEcCtD
Metronidazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000377	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00254	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00247	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00244	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00241	CbGpPWpGaD
Metronidazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000352	CcSEcCtD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.75e-05	0.00231	CbGpPWpGaD
Metronidazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000342	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.62e-05	0.00228	CbGpPWpGaD
Metronidazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000338	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.49e-05	0.00225	CbGpPWpGaD
Metronidazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000327	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.15e-05	0.00217	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.05e-05	0.00215	CbGpPWpGaD
Metronidazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000316	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.84e-05	0.0021	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.72e-05	0.00207	CbGpPWpGaD
Metronidazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000303	CcSEcCtD
Metronidazole—Rash—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000301	CcSEcCtD
Metronidazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000301	CcSEcCtD
Metronidazole—Headache—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.000299	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.38e-05	0.00199	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	8.28e-05	0.00197	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.26e-05	0.00196	CbGpPWpGaD
Metronidazole—Nausea—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000283	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.61e-05	0.0018	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.5e-05	0.00178	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.74e-05	0.0016	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.34e-05	0.00151	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.26e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.91e-05	0.0014	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.83e-05	0.00138	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.75e-05	0.00136	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.53e-05	0.00131	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.49e-05	0.0013	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.00129	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.44e-05	0.00129	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.34e-05	0.00127	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.96e-05	0.00118	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.81e-05	0.00114	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.47e-05	0.00106	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.45e-05	0.00106	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.43e-05	0.00105	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.34e-05	0.00103	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.04e-05	0.000958	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.95e-05	0.000938	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.000764	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.000699	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.92e-05	0.000692	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.88e-05	0.000684	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.86e-05	0.00068	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.69e-05	0.000638	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.66e-05	0.000632	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.63e-05	0.000624	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.42e-05	0.000575	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.000563	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.000557	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000519	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000508	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.00048	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.99e-05	0.000473	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000468	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.000441	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000418	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.64e-05	0.00039	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000385	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.000371	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000367	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000359	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.00034	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000335	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000309	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-05	0.000284	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000272	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000257	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000254	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.97e-06	0.000237	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	9.74e-06	0.000231	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.45e-06	0.000224	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	9.32e-06	0.000221	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.42e-06	0.000152	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.14e-06	0.000146	CbGpPWpGaD
